{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:42:31Z","timestamp":1773002551920,"version":"3.50.1"},"reference-count":128,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The view of paediatric cancer as a genetic disease arises as genetic research develops. Germline mutations in cancer predisposition genes have been identified in about 10% of children. Paediatric cancers are characterized by heterogeneity in the types of genetic alterations that drive tumourigenesis. Interactions between germline and somatic mutations are a key determinant of cancer development. In 40% of patients, the family history does not predict the presence of inherited cancer predisposition syndromes and many cases go undetected. Paediatricians should be aware of specific symptoms, which highlight the need of evaluation for cancer syndromes. The quickest possible identification of such syndromes is of key importance, due to the possibility of early detection of neoplasms, followed by presymptomatic genetic testing of relatives, implementation of appropriate clinical procedures (e.g., avoiding radiotherapy), prophylactic surgical resection of organs at risk, or searching for donors of hematopoietic stem cells. Targetable driver mutations and corresponding signalling pathways provide a novel precision medicine strategy.Therefore, there is a need for multi-disciplinary cooperation between a paediatrician, an oncologist, a geneticist, and a psychologist during the surveillance of families with an increased cancer risk. This review aimed to emphasize the role of cancer-predisposition gene diagnostics in the genetic surveillance and medical care in paediatric oncology.<\/jats:p>","DOI":"10.3390\/cancers14153569","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:53:45Z","timestamp":1658494425000},"page":"3569","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies\u2014A Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Aleksandra","family":"Filipiuk","sequence":"first","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, A. Rac\u0142awickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Kozakiewicz","sequence":"additional","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, A. Rac\u0142awickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-8831","authenticated-orcid":false,"given":"Kamil","family":"Ko\u015bmider","sequence":"additional","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, A. Rac\u0142awickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lejman","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic Diagnostics, Medical University of Lublin, A. Rac\u0142awickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-156X","authenticated-orcid":false,"given":"Joanna","family":"Zawitkowska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, A. Rac\u0142awickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.21873\/anticanres.14622","article-title":"Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review","volume":"40","author":"Kontomanolis","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1158\/1078-0432.CCR-17-0702","article-title":"Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr","volume":"23","author":"Brodeur","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gargallo, P., Oltra, S., Y\u00e1\u00f1ez, Y., Juan-Ribelles, A., Calabria, I., Segura, V., L\u00e1zaro, M., Balaguer, J., Tormo, T., and Dolz, S. (2021). Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care. Cancers, 13.","DOI":"10.3390\/cancers13215339"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Byrjalsen, A., Hansen, T., Stoltze, U., Mehrjouy, M., Barnkob, N., Hjalgrim, L., Mathiasen, R., Lautrup, C., Gregersen, P., and Hasle, H. (2020). Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. PLoS Genet., 16.","DOI":"10.1371\/journal.pgen.1009231"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2015.10080","article-title":"Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth","volume":"314","author":"Mody","year":"2015","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aaw3535","article-title":"The genomic landscape of pediatric cancers: Implications for diagnosis and treatment","volume":"363","author":"Biegel","year":"2019","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline Mutations in Predisposition Genes in Pediatric Cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","article-title":"Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia","volume":"13","author":"Bloom","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10555-019-09836-y","article-title":"Compare and contrast: Pediatric cancer versus adult malignancies","volume":"38","author":"Kattner","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001\u20132010: A population-based registry study","volume":"18","author":"Colombet","year":"2017","journal-title":"Lancet. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1470-2045(19)30339-0","article-title":"The global burden of childhood and adolescent cancer in 2017: An analysis of the Global Burden of Disease Study","volume":"20","author":"Force","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(18)30761-7","article-title":"Childhood cancer burden: A review of global estimates","volume":"20","author":"Bhakta","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Seemanova, E., Varon, R., Vejvalka, J., Jarolim, P., Seeman, P., Chrzanowska, K.H., Digweed, M., Resnick, I., Kremensky, I., and Saar, K. (2016). The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167984"},{"key":"ref_14","first-page":"575","article-title":"Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome","volume":"27","author":"Pastorczak","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: Management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.mayocp.2019.12.013","article-title":"Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers","volume":"95","author":"Mangaonkar","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3389\/fimmu.2018.02912","article-title":"Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group","volume":"9","author":"Bomken","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108386","DOI":"10.1016\/j.mrrev.2021.108386","article-title":"Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants","volume":"788","author":"Szmyd","year":"2021","journal-title":"Mutat. Res.\/Rev. Mutat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, Presentation, and Prognosis of Malignancies in Ataxia-Telangiectasia: A Report From the French National Registry of Primary Immune Deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: A review","volume":"11","author":"Wright","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: Immunodeficiency and survival","volume":"178","author":"Jansen","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-7-13","article-title":"Nijmegen breakage syndrome (NBS)","volume":"7","author":"Chrzanowska","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fimmu.2017.00807","article-title":"Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT)","volume":"8","author":"Deripapa","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3389\/fimmu.2020.01319","article-title":"T Lymphocytes in Patients With Nijmegen Breakage Syndrome Demonstrate Features of Exhaustion and Senescence in Flow Cytometric Evaluation of Maturation Pathway","volume":"11","author":"Piatosa","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3389\/fimmu.2019.02322","article-title":"Antioxidant Defense, Redox Homeostasis, and Oxidative Damage in Children with Ataxia Telangiectasia and Nijmegen Breakage Syndrome","volume":"10","author":"Maciejczyk","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1158\/1078-0432.CCR-17-0465","article-title":"Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders","volume":"23","author":"Walsh","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom\u2019s Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition","volume":"8","author":"Cunniff","year":"2016","journal-title":"Mol. Syndromol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2021.03.003","article-title":"Bloom syndrome and the underlying causes of genetic instability","volume":"133","author":"Ababou","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_31","unstructured":"Adam, M.P. (2006). Bloom Syndrome. GeneReviews\u00ae, University of Washington."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","article-title":"Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortium","volume":"50","author":"Bakry","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","article-title":"Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood","volume":"23","author":"Tabori","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cge.12904","article-title":"Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type","volume":"91","author":"Wimmer","year":"2017","journal-title":"Clin. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmg.2015.12.014","article-title":"Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome","volume":"59","author":"Ripperger","year":"2016","journal-title":"Eur. J. Med Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ejca.2015.02.008","article-title":"Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome","volume":"51","author":"Durno","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_37","first-page":"1","article-title":"Constitutional mismatch repair deficiency\u2013associated brain tumors: Report from the European C4CMMRD consortium","volume":"1","author":"Varlet","year":"2019","journal-title":"Neuro Oncol. Adv."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Martens, M., Emmert, S., and Boeckmann, L. (2021). Xeroderma Pigmentosum: Gene Variants and Splice Variants. Genes, 12.","DOI":"10.3390\/genes12081173"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0043-123031","article-title":"Xeroderma pigmentosum\u2014Facts and Perspectives","volume":"44","author":"Lehmann","year":"2018","journal-title":"Aktuelle Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-030-46227-7_16","article-title":"Sunlight, Vitamin D, and Xeroderma Pigmentosum","volume":"1268","author":"Martens","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cancergen.2011.04.005","article-title":"Pediatric leukemia predisposition syndromes: Clues to understanding leukemogenesis","volume":"204","author":"Seif","year":"2011","journal-title":"Cancer Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41572-019-0113-0","article-title":"Chromosome instability syndromes","volume":"5","author":"Taylor","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_46","unstructured":"Garofola, C., Nassereddin, A., and Gross, G.P. (2022, July 02). Dyskeratosis Congenita, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507710\/."},{"key":"ref_47","first-page":"943","article-title":"Dyskeratosis congenita: A literature review","volume":"18","author":"AlSabbagh","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40291-018-0368-2","article-title":"Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives","volume":"23","author":"Bezzerri","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"ref_49","unstructured":"Nelson, A., and Myers, K. (2022, April 02). Shwachman-Diamond Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1756\/."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: A multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood.2019000947","article-title":"Diamond-Blackfan anemia","volume":"136","author":"Leblanc","year":"2020","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.15701","article-title":"How I manage children with Diamond-Blackfan anaemia","volume":"184","author":"Bartels","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: A report from the Diamond Blackfan Anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/10428194.2015.1115041","article-title":"Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults","volume":"57","author":"Babushok","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukaemias and myeloid neoplasms","volume":"21","author":"Klco","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","article-title":"Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions","volume":"23","author":"Porter","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/sji.12913","article-title":"Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management","volume":"92","author":"Vakkilainen","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jmg.29.9.652","article-title":"Cartilage-hair hypoplasia in Finland: Epidemiological and genetic aspects of 107 patients","volume":"29","author":"Makitie","year":"1992","journal-title":"J. Med Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma","volume":"146A","author":"Taskinen","year":"2008","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","article-title":"Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome","volume":"38","author":"Candotti","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MOH.0b013e328353fa13","article-title":"Lymphoma complicating primary immunodeficiency syndromes","volume":"19","author":"Leechawengwongs","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2018.06.011","article-title":"Hematological Malignancies Associated With Primary Immunodeficiency Disorders","volume":"194","author":"Duan","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101197","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"ref_68","unstructured":"Roberts, A. (2022, April 02). Noonan Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1124\/."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1158\/1078-0432.CCR-17-0631","article-title":"Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk","volume":"23","author":"Villani","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","article-title":"Health Supervision for Children With Neurofibromatosis Type","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sur, M., Armat, I., Sur, G., Pop, D., Samasca, G., Lupan, I., Timis, T., Florian, I., and Sur, D. (2022). Neurofibromatosis in Children: Actually and Perspectives. Children, 9.","DOI":"10.3390\/children9010040"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Pinti, E., Nemeth, K., Staub, K., Lengyel, A., Fekete, G., and Haltrich, I. (2021). Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. BMC Pediatr., 21.","DOI":"10.1186\/s12887-021-02791-0"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2018.1.307","article-title":"JMML genomics and decisions","volume":"2018","author":"Niemeyer","year":"2018","journal-title":"Hematology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1158\/1078-0432.CCR-17-0589","article-title":"Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis","volume":"23","author":"Evans","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_76","first-page":"394","article-title":"Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations","volume":"167A","author":"Lissewski","year":"2015","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.18632\/oncotarget.233","article-title":"Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders","volume":"2","author":"Naramura","year":"2011","journal-title":"Oncotarget"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e04260","DOI":"10.1002\/ccr3.4260","article-title":"Juvenile myelomonocytic leukemia in CBL syndrome associated with germline splice-site mutations: Two case reports and a literature review","volume":"9","author":"Cardoso","year":"2021","journal-title":"Clin. Case Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.13096","article-title":"Haematopoietic development and leukaemia in Down syndrome","volume":"167","author":"Roberts","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pcl.2007.11.001","article-title":"Acute Leukemias in Children with Down Syndrome","volume":"55","author":"Zwaan","year":"2008","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-8935-6-18","article-title":"Constitutional trisomy 8 mosaicism as a model for epigenetic studies of aneuploidy","volume":"6","author":"Davidsson","year":"2013","journal-title":"Epigenet. Chromatin"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s42000-020-00241-7","article-title":"Oncologic manifestations of Klinefelter syndrome","volume":"19","author":"Rojas","year":"2020","journal-title":"Hormones"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.30126","article-title":"Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study","volume":"139","author":"Ji","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.14258","article-title":"Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia","volume":"179","author":"Rau","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3324\/haematol.2015.130799","article-title":"Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family","volume":"101","author":"Pathak","year":"2015","journal-title":"Haematologica"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.seminhematol.2017.04.001","article-title":"Familial CEBPA-mutated acute myeloid leukemia","volume":"54","author":"Tawana","year":"2017","journal-title":"Semin. Hematol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2016.10.003","article-title":"Genetic predisposition to leukemia and other hematologic malignancies","volume":"43","author":"Feurstein","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia","volume":"33","author":"Churchman","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/humu.21600","article-title":"Extending the phenotypes associated with DICER1 mutations","volume":"32","author":"Foulkes","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00431-015-2660-z","article-title":"Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome","volume":"175","author":"Kuhlen","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","article-title":"PTEN, DICER1, FH, and Their Associated Tumour Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Schultz","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/nop\/npab012","article-title":"Genetic syndromes predisposing to pediatric brain tumors","volume":"8","author":"Walsh","year":"2021","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_97","first-page":"42","article-title":"Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline","volume":"82","author":"Kratz","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajmg.a.38142","article-title":"Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology","volume":"173","author":"Ripperger","year":"2017","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12185-017-2259-4","article-title":"Germline ETV6 mutations and predisposition to hematological malignancies","volume":"106","author":"Feurstein","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e2129742","DOI":"10.1001\/jamanetworkopen.2021.29742","article-title":"Estimated Cost-effectiveness of Genetic Testing in Siblings of Newborns With Cancer Susceptibility Gene Variants","volume":"4","author":"Christensen","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_106","first-page":"1366","article-title":"Universal newborn genetic screening for pediatric cancer predisposition syndromes: Model-based insights","volume":"23","author":"Yeh","year":"2021","journal-title":"Genet. Med. Off. J. Am. Coll. Med Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.19.02010","article-title":"Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening","volume":"38","author":"Offit","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40142-015-0064-z","article-title":"Unique Genetic Counseling Considerations in the Pediatric Oncology Setting","volume":"3","author":"Jasperson","year":"2015","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_109","unstructured":"NSGC (2022, April 02). Policy, Research and Publications. Professional Status Survey. Available online: https:\/\/www.nsgc.org\/Policy-Research-and-Publications\/Professional-Status-Survey."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmg.2016.01.008","article-title":"Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool","volume":"59","author":"Jongmans","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1158\/1078-0432.CCR-17-0834","article-title":"Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient","volume":"23","author":"Druker","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jamaoncol.2015.5699","article-title":"Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children with Solid Tumors","volume":"2","author":"Parsons","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.21.00018","article-title":"Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors","volume":"39","author":"Cullinan","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e26441","DOI":"10.1002\/pbc.26441","article-title":"The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation","volume":"64","author":"Goudie","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/jamaoncol.2021.4536","article-title":"Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes","volume":"7","author":"Goudie","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1002\/cphg.98","article-title":"Clinical Interpretation of Sequence Variants","volume":"106","author":"Zhang","year":"2020","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/23808993.2019.1599685","article-title":"Privacy and ethical challenges in next-generation sequencing","volume":"4","author":"Magnus","year":"2019","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/pbc.25815","article-title":"Is Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients with Solid Tumors","volume":"63","author":"McCullough","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/2159-8290.CD-20-1631","article-title":"Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing","volume":"11","author":"Newman","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13073-019-0644-8","article-title":"Clinical utility of custom-designed NGS panel testing in pediatric tumors","volume":"11","author":"Surrey","year":"2019","journal-title":"Genome Med."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Langenberg, K., Looze, E.J., and Molenaar, J.J. (2021). The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development. Cancers, 13.","DOI":"10.3390\/cancers13174324"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fped.2017.00265","article-title":"Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience","volume":"5","author":"Marks","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/archdischild-2016-311251","article-title":"Clinical presentation of childhood leukaemia: A systematic review and meta-analysis","volume":"101","author":"Clarke","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","article-title":"Lymphoblastic lymphoma","volume":"113","author":"Cortelazzo","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e27629","DOI":"10.1002\/pbc.27629","article-title":"Cost-effectiveness of early cancer surveillance for patients with Li\u2013Fraumeni syndrome","volume":"66","author":"Tak","year":"2019","journal-title":"Pediatr. Blood Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3569\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:54:43Z","timestamp":1760140483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":128,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["cancers14153569"],"URL":"https:\/\/doi.org\/10.3390\/cancers14153569","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}